Corvus Pharmaceuticals
CRVS
$1.58
Share price
8.97%
Change (1 day)
42.34%
Change (1 year)
Categories
Corvus Pharmaceuticals (CRVS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $6.86 M
According to Corvus Pharmaceuticals 's latest financial reports the company's total liabilities are $6.86 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Corvus Pharmaceuticals - Total liabilities on balance sheet (from 2015 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $12.12 M | -1.37% |
| 2021-12-31 | $12.29 M | -8.13% |
| 2020-12-31 | $13.38 M | 6.75% |
| 2019-12-31 | $12.53 M | 58.75% |
| 2018-12-31 | $7.89 M | -20.56% |
| 2017-12-31 | $9.94 M | 35.26% |
| 2016-12-31 | $7.34 M | -94.33% |
| 2015-12-31 | $0.12 B | 921.12% |
| 2014-12-31 | $12.68 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 306.45% | 🇺🇸 USA |